Criteria
Leader criteria
Sector
Communication Services
0
Consumer Discretionary
6
Consumer Staples
1
Energy
16
Financials
1
Health Care
10
Industrials
13
Information Technology
16
Materials
5
Real Estate
0
Utilities
0
Russell 3000. FTSE Russell does not publish this list, so it is reconstructed here as the 3,000 largest US operating companies by market value. It will not match the published index name for name.
Stage 2 Leader · Russell 3000
| Ticker ▲ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen Inc | Health Care | $466.01 | up 6.1% | up 10.6% | up 64.0% | 2.5% | 90 | 8/8 | $251.1B | 32.6× | 0.37 | up 106% | 29.0× | 5.78 | up 65% | 7/9 | Moderate | |
| AXGN | Axogen, Inc. | Health Care | $49.37 | up 29.7% | up 17.8% | up 117.7% | 4.8% | 90 | 8/8 | $2.3B | — | — | down 13% | 18.1× | 0.38 | up 163% | 5/9 | Low | |
| BTSG | Brightspring Health Services, Inc. | Health Care | $66.89 | up 11.3% | up 17.9% | up 104.0% | 3.8% | 91 | 8/8 | $12.9B | 68.0× | 0.10 | up 11% | 6.9× | 1.31 | up 78% | 7/9 | Moderate | |
| CON | Concentra Group Holdings Parent, Inc. | Health Care | $40.38 | up 2.9% | up 17.3% | up 103.1% | 2.3% | 95 | 8/8 | $5.2B | 31.2× | — | up 50% | 13.2× | 3.98 | up 47% | — | Moderate | |
| DGX | Quest Diagnostics Inc | Health Care | $251.82 | up 4.1% | up 8.4% | up 45.2% | 2.5% | 82 | 8/8 | $40.8B | 41.1× | 2.96 | up 14% | 5.7× | 0.72 | up 28% | 6/9 | Low | |
| EXEL | Exelixis, Inc. | Health Care | $69.39 | up 7.5% | up 18.8% | up 78.2% | 2.7% | 93 | 8/8 | $18.2B | 23.3× | 0.40 | up 36% | 8.4× | — | up 23% | 7/9 | Low | |
| HALO | Halozyme Therapeutics, Inc. | Health Care | $130.91 | up 4.2% | up 18.6% | up 102.6% | 2.5% | 97 | 8/8 | $15.4B | 48.7× | — | up 154% | 315.9× | 43.89 | up 43% | 5/9 | Low | |
| PGNY | Progyny, Inc. | Health Care | $29.19 | up 0.8% | up 15.9% | up 56.5% | 3.0% | 80 | 8/8 | $2.4B | 41.6× | 2.89 | up 12% | 4.7× | — | up 79% | 8/9 | Low | |
| PNTG | Pennant Group, Inc. | Health Care | $41.66 | down 0.5% | up 6.8% | up 69.3% | 3.2% | 87 | 8/8 | $1.4B | 48.8× | 2.59 | up 9% | 3.9× | 0.45 | up 26% | — | Moderate | |
| WST | West Pharmaceutical Services Inc | Health Care | $412.62 | up 5.2% | up 11.3% | up 48.6% | 2.5% | 90 | 8/8 | $29.7B | 60.2× | 38.06 | up 17% | 9.4× | 0.06 | up 57% | 8/9 | Low |